Related Experiment Video
Updated: Aug 30, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
[Antituberculosis chemoprophylaxis in a public hospital - study of 100 children]
Clemax C. Sant'Anna1, Solange G. David, Anna M. Marques
1Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.
Insights
This study evaluated tuberculosis chemoprophylaxis in children, finding that while 15% adhered to guidelines, 85% were prescribed treatment for high-risk groups. Adherence to national guidelines for pediatric tuberculosis prevention needs improvement.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Antituberculosis chemoprophylaxis is crucial for preventing active tuberculosis in children, especially those exposed to infected individuals or with specific risk factors.
- National guidelines aim to standardize chemoprophylaxis, but adherence and effectiveness in diverse pediatric populations require evaluation.
- Special considerations exist for very young children, BCG-vaccinated children with positive tuberculin skin tests, and those with recent or current exposure to tuberculosis.
Purpose of the Study:
- To assess the adherence to National Tuberculosis Control Program guidelines for antituberculosis chemoprophylaxis in children.
- To evaluate the application of these recommendations in special pediatric situations, including high-risk groups.
- To analyze factors influencing chemoprophylaxis outcomes, such as adherence, monotherapy failure, and side effects.
Main Methods:
- A retrospective cross-sectional study was conducted on 100 children receiving chemoprophylaxis at a public hospital in Rio de Janeiro.
- Data collected included demographics, BCG vaccination status, nutritional status, tuberculin skin test results, tuberculosis exposure, and treatment adherence.
- Analysis focused on adherence to guidelines, identification of infection sources, monotherapy failure rates, and isoniazid side effects.
Main Results:
- The study included 57% males and 43% females; 62% were under five years old.
- 92% had prior BCG vaccination, 28% presented with malnutrition, and 9% were recent tuberculosis converters.
- Parents were the source of infection in 60% of known cases; 73% adhered to chemoprophylaxis, with 1% experiencing monotherapy failure and 1% reporting isoniazid side effects.
Conclusions:
- Only 15% of children fully followed Health Department guidelines, including those with recent tuberculosis converters.
- The majority (85%) of recommended chemoprophylaxis was administered to cover high-risk pediatric groups.
- Findings suggest a need to improve adherence to established national guidelines for pediatric tuberculosis chemoprophylaxis, particularly for vulnerable populations.
Abstract:
OBJECTIVE: To evaluate recommendations for antituberculosis chemoprophylaxis in children according to the guidelines of the National Tuberculosis Control Program, and in special situations, as very young children, BCG vaccinated children with positive tuberculin skin test and recent or current exposure to infected cases. METHODS: A retrospective cross-section study has been made of 100 children who underwent chemoprophylaxis at a public hospital in Rio de Janeiro. Variables analyzed were sex, age, BCG vaccination, nutritional status, tuberculin skin test, recent tuberculosis converters, infection source for tuberculosis, adherence to prevention, monotherapy failure and isoniazid side effects. RESULTS: The case history was made up of 57 males and 43 females, 62% were younger than five years of age, there was reference to previous BCG vaccination in 92%, malnutrition in 28% and recent tuberculosis converters in 9% of the cases. Parents represented 60% of infection source known, there was adherence to prevention in 73%, monotherapy failure in 1% and isoniazid side effects in 1% of the cases. CONCLUSIONS: It has been concluded that 15% followed the Health Department guidelines thoroughly, which included the 9 cases of recent tuberculosis converters; 85% of the recommended chemoprophylaxis were due to the coverage of high-risk groups to develop the disease.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Antiprotozoal Agents
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...